We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » California AG Issues More Subpoenas Over Antipsychotic Drug Marketing
California AG Issues More Subpoenas Over Antipsychotic Drug Marketing
November 6, 2006
Eli Lilly, Pfizer and Bristol-Myers Squibb (BMS) have joined AstraZeneca as targets of subpoenas from the California Office of the Attorney General over marketing practices for top-selling antipsychotic drugs.